References
- Yun J, Li Y, Xu CT, Pan BR. Epidemiology and Rb1 gene of retinoblastoma. Int J Ophthalmol. 2011;4:103–9. doi:https://doi.org/10.3980/j.issn.2222-3959.2011.01.24.
- Dimaras H, Corson TW. Retinoblastoma, the visible CNS tumor: a review. J Neuro Res. 2019;97:29–44. doi:https://doi.org/10.1002/jnr.24213.
- Gohari M, Dastgheib SA, Noorishadkam M, Lookzadeh MH, Mirjalili SR, Akbarian-Bafghi MJ, et al. Association of eNOS and ACE polymorphisms with retinopathy of prematurity: a systematic review and meta-analysis. Fetal Pediatr Pathol. 2019;1–12. doi:https://doi.org/10.1080/15513815.2019.1652378. [Epub ahead of print].
- Heck JE, Lombardi CA, Meyers TJ, Cockburn M, Wilhelm M, Ritz B. Perinatal characteristics and retinoblastoma. Cancer Causes Control. 2012;23:1567–75. doi:https://doi.org/10.1007/s10552-012-0034-7.
- Alnawaiseh I, Jaradat I, Yousef YA, Mehyar M, Sultan I, Khurma S, Al-Rawashded K, Wilson M, Qaddoumi I, Salem A, et al. Retinoblastoma in Jordan: an epidemiological study (2006–2010). Hematol/Oncol Stem Cell Ther. 2011;4:126–31. doi:https://doi.org/10.5144/1658-3876.2011.126.
- Singh L, Kashyap S. Update on pathology of retinoblastoma. Int J Ophthalmol. 2018;11:2011–16. doi:https://doi.org/10.18240/ijo.2018.12.22.
- Houston SK, Murray TG, Wolfe SQ, Fernandes CE. Current update on retinoblastoma. International Ophthalmology Clinics. 2011;51:77–91. doi:https://doi.org/10.1097/IIO.0b013e3182010f29.
- Singh G, Daniels AB. Disparities in retinoblastoma presentation, treatment, and outcomes in developed and less-developed countries. Semin Ophthalmol. 2016;31:310–16. doi:https://doi.org/10.3109/08820538.2016.1154177.
- Mastrangelo D, Francesco Di Leonardo DS, Lentini A, Hadjistilianou L. T. The retinoblastoma paradigm revisited. Med Sci Monit. 2008;14:RA231–40.
- Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Does the evidence matter in medicine? The retinoblastoma paradigm. Int J Cancer. 2007;121:2501–5. doi:https://doi.org/10.1002/ijc.22944.
- Chinnam M, Goodrich DW. RB1, development, and cancer. Curr Top Dev Biol. 2011;94:129–69. doi:https://doi.org/10.1016/B978-0-12-380916-2.00005-X.
- Singh N, Lim RB, Sawyer MA. The cell cycle. Hawaii Med J. 2000;59:300–6. doi:https://doi.org/10.1634/theoncologist.5-6-510.
- Parma D, Ferrer M, Luce L, Giliberto F, Szijan I. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling. PloS One. 2017;12:e0189736. doi:https://doi.org/10.1371/journal.pone.0189736.
- Farid M, Ngeow J. Sarcomas associated with genetic cancer predisposition syndromes: a review. Oncologist. 2016;21:1002–13. doi:https://doi.org/10.1634/theoncologist.2016-0079.
- Kleinerman RA, Schonfeld SJ, Tucker MA. Sarcomas in hereditary retinoblastoma. Clin Sarcoma Res. 2012;2:15. doi:https://doi.org/10.1186/2045-3329-2-15.
- Francis JH, Levin AM, Abramson DH. Update on ophthalmic oncology 2014. Asia-Pacific Journal of Ophthalmology. 2016;5:368–82. doi:https://doi.org/10.1097/APO.0000000000000213.
- Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC, Squire JA, et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008;17:1363–72. doi:https://doi.org/10.1093/hmg/ddn024.
- McEvoy J, Ulyanov A, Brennan R, Wu G, Pounds S, Zhang J, Dyer MA. Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma. PLoS One. 2012;7:e42739. doi:https://doi.org/10.1371/journal.pone.0042739.
- Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv Nutr. 2012;3:21–38. doi:https://doi.org/10.3945/an.111.000992.
- Niktabar SM, Aarafi H, Dastgheib SA, Noorishadkam M, Mirjalili SR, Lookzadeh MH, et al. Association of MTHFR 1298A > C polymorphism with susceptibility to non-syndromic cleft lip with or without palate: a case-control study and meta-analysis. Fetal Pediatr Pathol. 2019:1–17. doi:https://doi.org/10.1080/15513815.2019.1683918. [Epub ahead of print].
- Wang W, Jiao X-H, Wang X-P, Sun X-Y, Dong C. MTR, MTRR, and MTHFR gene polymorphisms and susceptibility to nonsyndromic cleft lip with or without cleft palate. Genet Test Mol Biomarkers. 2016;20:297–303. doi:https://doi.org/10.1089/gtmb.2015.0186.
- Orjuela MA, Cabrera-Muñoz L, Paul L, Ramirez-Ortiz MA, Liu X, Chen J, Mejia-Rodriguez F, Medina-Sanson A, Diaz-Carreño S, Suen IH, et al. Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake. Cancer. 2012;118:5912–19. doi:https://doi.org/10.1002/cncr.27621.
- Wan Ismail WR, Abdul Rahman R, Rahman NAA, Atil A, Nawi AM. The protective effect of maternal folic acid supplementation on childhood cancer: a systematic review and meta-analysis of case-control studies. J Prev Med Public Health. 2019;52:205–13. doi:https://doi.org/10.3961/jpmph.19.020.
- Azarpira MR, Ghilian MM, Sobhan MR, Mehdinezhad-Yazdi M, Aghili K, Miresmaeili SM, Neamatzadeh H. Association of MTHFR and TNF-α genes polymorphisms with susceptibility to Legg-Calve-Perthes disease in Iranian children: a case-control study. J Orthopaed. 2018;15:984–7. doi:https://doi.org/10.1016/j.jor.2018.08.042.
- Gohari M, Dastgheib AS, Jafari-Nedooshan J, Akbarian-Bafghi JM, Morovati-Sharifabad M, Mirjalili RS, et al. Association of MTHFR 677C > T, 1298A > C and MTR 2756A > G Polymorphisms with Risk of Retinoblastoma. Klin Onkol. 2019;32:375–9. doi:https://doi.org/10.14735/amko2019375.
- de Lima ELS, da Silva VC, da Silva HDA, Bezerra AM, de Morais VLL, de Morais AL, et al. MTR polymorphic variant A2756G and retinoblastoma risk in Brazilian children. Pediatr Blood Cancer. 2010;54:n–n/a. /a- doi:https://doi.org/10.1002/pbc.22472.
- Soleimani E, Saliminejad K, Akbari MT, Kamali K, Ahani A. Association study of the common polymorphisms in the folate-methionine pathway with retinoblastoma. Ophthalmic Genet. 2016;37:384–7. doi:https://doi.org/10.3109/13816810.2015.1107596.
- Bisht S, Chawla B, Dada R. Oxidative stress and polymorphism in MTHFR SNPs (677 and 1298) in paternal sperm DNA is associated with an increased risk of retinoblastoma in their children: a case–control study. J Pediatr Genet. 2018;7:103–13. doi:https://doi.org/10.1055/s-0038-1667037.
- Akbari MT, Naderi A, Saremi L, Sayad A, Irani S, Ahani A. Methionine synthase A2756G variation is associated with the risk of retinoblastoma in Iranian children. Cancer Epidemiol. 2015;39:1023–5. doi:https://doi.org/10.1016/j.canep.2015.11.002.
- Karimi-Zarchi M, Moghimi M, Abbasi H, Hadadan A, Salimi E, Morovati-Sharifabad M, Akbarian-Bafghi MJ, Zare-Shehneh M, Mosavi-Jarrahi A, Neamatzadeh H, et al. Association of MTHFR 677C > T polymorphism with susceptibility to ovarian and cervical cancers: A systematic review and meta-analysis. Asian Pac J Cancer Prev. 2019;20:2569–77. doi:https://doi.org/10.31557/APJCP.2019.20.9.2569.
- Sadeghiyeh T, Dastgheib SA, Mirzaee-Khoramabadi K, Morovati-Sharifabad M, Akbarian-Bafghi MJ, Poursharif Z, Mirjalili SR, Neamatzadeh H. Association of MTHFR 677C > T and 1298A > C polymorphisms with susceptibility to autism: a systematic review and meta-analysis. Asian J Psychiatry. 2019;46:54–61. doi:https://doi.org/10.1016/j.ajp.2019.09.016.
- Ding W, Zhou D, Jiang X, Lu L. Methionine synthase a2756g polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies. PLoS One. 2013;8:e60508. doi:https://doi.org/10.1371/journal.pone.0060508.
- Zhao Y, Chen Z, Ma Y, Xia Q, Zhang F, Fu D, Wang X-F. Lack of association between methionine synthase A2756G polymorphism and digestive system cancer risk: evidence from 39327 subjects. PLoS One. 2013;8:e61511. doi:https://doi.org/10.1371/journal.pone.0061511.
- Mahmoud AM, Ali MM. Methyl donor micronutrients that modify DNA methylation and cancer outcome. Nutrients. 2019;11:608. pii: doi:https://doi.org/10.3390/nu11030608.
- Brandalize APC, Bandinelli E, Borba JB, Félix TM, Roisenberg I, Schüler-Faccini L. Polymorphisms in genes MTHFR, MTR and MTRR are not risk factors for cleft lip/palate in South Brazil. Braz J Med Biol Res. 2007;40:787–91. doi:https://doi.org/10.1590/S0100-879X2006005000112.
- Milne E, Greenop KR, Scott RJ, Haber M, Norris MD, Attia J, Jamieson SE, Miller M, Bower C, Bailey HD, et al. Folate pathway gene polymorphisms, maternal folic acid use, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2015;24:48–56. doi:https://doi.org/10.1158/1055-9965.EPI-14-0680.
- Rai V, Yadav U, Kumar P, Yadav SK, Mishra OP. Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies. PLoS One. 2014;9:e108552. doi:https://doi.org/10.1371/journal.pone.0108552.
- Zhang Q, Bai B, Liu X, Miao C, Li H. Association of folate metabolism genes MTHFR and MTRR with multiple complex congenital malformation risk in Chinese population of Shanxi. Transl Pediatr. 2014;3:259–67. doi:https://doi.org/10.3978/j.issn.2224-4336.2014.07.10.
- Jacquesson-Fournols L, Alvarez S, Cohen M, Clement P, Menezo Y. A paternal effect of MTHFR SNPs on gametes and embryos should not be overlooked: case reports. J Assist Reprod Genet. 2019;36:1351–3. doi:https://doi.org/10.1007/s10815-019-01488-9.